Idera Reports Clinical Hold on Proposed Phase 2 Clinical Trial of IMO-3100 - MarketWatch (press release)

Idera Reports Clinical Hold on Proposed state of matter 2 Clinical Trial of IMO-3100 MarketWatch (press release) The proposed Phase ii trial of IMO-3100 is for the treatment of psoriasis . A clinical hold is an bid issued by the FDA to the sponsor of a clinical trial to delay a proposed clinical trial or suspend AN ongoing clinical trial. ... and more » Link To Article